摘要
目的探讨危重症患者监测血糖的临床作用。方法对我院收治的危重症患者632例进行随机常规血糖监测,其中385例患者血糖升高,对血糖升高患者进行糖化血红蛋白(glycated hemoglobin,GHb)测定,根搌GHb结果,统计分析GHb正常组与GHb升高组患者的临床糖尿病确诊率及病死率。结果危重症血糖正常患者病死率明显低于血糖升高者(P<0.05);GHb正常组患者糖尿病确诊率及病死率显著低于GHb升高组患者(P<0.05);而GHb升高组患者中无糖尿病史较有糖尿病史患者的病死率升高,差异有统计学意义(P<0.05)。结论重视危重症患者血糖的测定及评估,可以为临床诊治提供科学的参考依据,并可以改善患者的预后。
Objective To explore clinical monitor effect of blood glucose in the critically ill patients. Methods 632 cases of the critical disease, random got routine blood glucose monitoring, including 385 patients with high blood sugar,high blood sugar to patients with glycated hemoglobin （glycated hemoglobin,GHb）test,the root Zhan GHb results, statistical analysis the normal group and increased GHb GHb patients diagnosed diabetes clinical morbidity and mortality rates.Results patients with normal blood sugar critical disease mortality rate was significantly lower than the high blood sugar critically ill patients with disease （P〈0.05）;The increase in blood sugar GHb normal group patients diagnosed diabetes morbidity and mol^ality rates rise significantly below GHb group patients （P〈0.05） ; And increased in patients with GHb group has no obvious history of diabetes patients with diabetes is the history of increased mortality, the difference was statistically significant （P〈0.05）.Conclusions Determination and evaluation of blood sugar in patients with critical disease, could provide scientific reference for diagnosis and treatment, and can improve the prognosis of patients.
出处
《基层医学论坛》
2013年第4期491-492,共2页
The Medical Forum
关键词
危重症
高血糖
糖尿病
病死率
Critical sickness High blood glucose levels Diabetes The mortality rate
